Literature DB >> 22068567

Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.

Lianchun Fan1, Ibrahim Kadura, Lara E Krebs, Christopher C Hatfield, Margaret M Shaw, Christopher C Frye.   

Abstract

Although Chinese hamster ovary (CHO) cells, with their unique characteristics, have become a major workhorse for the manufacture of therapeutic recombinant proteins, one of the major challenges in CHO cell line generation (CLG) is how to efficiently identify those rare, high-producing clones among a large population of low- and non-productive clones. It is not unusual that several hundred individual clones need to be screened for the identification of a commercial clonal cell line with acceptable productivity and growth profile making the cell line appropriate for commercial application. This inefficiency makes the process of CLG both time consuming and laborious. Currently, there are two main CHO expression systems, dihydrofolate reductase (DHFR)-based methotrexate (MTX) selection and glutamine synthetase (GS)-based methionine sulfoximine (MSX) selection, that have been in wide industrial use. Since selection of recombinant cell lines in the GS-CHO system is based on the balance between the expression of the GS gene introduced by the expression plasmid and the addition of the GS inhibitor, L-MSX, the expression of GS from the endogenous GS gene in parental CHOK1SV cells will likely interfere with the selection process. To study endogenous GS expression's potential impact on selection efficiency, GS-knockout CHOK1SV cell lines were generated using the zinc finger nuclease (ZFN) technology designed to specifically target the endogenous CHO GS gene. The high efficiency (∼2%) of bi-allelic modification on the CHO GS gene supports the unique advantages of the ZFN technology, especially in CHO cells. GS enzyme function disruption was confirmed by the observation of glutamine-dependent growth of all GS-knockout cell lines. Full evaluation of the GS-knockout cell lines in a standard industrial cell culture process was performed. Bulk culture productivity improved two- to three-fold through the use of GS-knockout cells as parent cells. The selection stringency was significantly increased, as indicated by the large reduction of non-producing and low-producing cells after 25 µM L-MSX selection, and resulted in a six-fold efficiency improvement in identifying similar numbers of high-productive cell lines for a given recombinant monoclonal antibody. The potential impact of GS-knockout cells on recombinant protein quality is also discussed.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068567     DOI: 10.1002/bit.24365

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  26 in total

1.  Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing.

Authors:  Ayal Hendel; Eric J Kildebeck; Eli J Fine; Joseph Clark; Niraj Punjya; Vittorio Sebastiano; Gang Bao; Matthew H Porteus
Journal:  Cell Rep       Date:  2014-03-27       Impact factor: 9.423

2.  Identification and characterization of a -1 reading frameshift in the heavy chain constant region of an IgG1 recombinant monoclonal antibody produced in CHO cells.

Authors:  Zhirui Lian; Qindong Wu; Tongtong Wang
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

3.  Comparative Proteomic Analysis of Three Chinese Hamster Ovary (CHO) Host Cells.

Authors:  Ningning Xu; Chao Ma; Jianfa Ou; Wanqi Wendy Sun; Lufang Zhou; Hui Hu; Xiaoguang Margaret Liu
Journal:  Biochem Eng J       Date:  2017-05-15       Impact factor: 3.978

4.  Complete knockout of the lactate dehydrogenase A gene is lethal in pyruvate dehydrogenase kinase 1, 2, 3 down-regulated CHO cells.

Authors:  Shirley S M Yip; Meixia Zhou; John Joly; Bradley Snedecor; Amy Shen; Yongping Crawford
Journal:  Mol Biotechnol       Date:  2014-09       Impact factor: 2.695

Review 5.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

6.  Rational design and construction of multi-copy biomanufacturing islands in mammalian cells.

Authors:  Raffaele Altamura; Jiten Doshi; Yaakov Benenson
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

7.  Engineering a synthesis-friendly serum responsive promoter for antibiotic selection of genomic integration in cell-based therapy.

Authors:  Chee Ka Candice Lam; Kevin Truong
Journal:  Biotechnol Lett       Date:  2022-03-16       Impact factor: 2.461

8.  Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.

Authors:  Tao Dao; Dmitry Pankov; Andrew Scott; Tatyana Korontsvit; Victoriya Zakhaleva; Yiyang Xu; Jingyi Xiang; Su Yan; Manuel Direito de Morais Guerreiro; Nicholas Veomett; Leonid Dubrovsky; Michael Curcio; Ekaterina Doubrovina; Vladimir Ponomarev; Cheng Liu; Richard J O'Reilly; David A Scheinberg
Journal:  Nat Biotechnol       Date:  2015-09-21       Impact factor: 54.908

9.  Improvements in protein production in mammalian cells from targeted metabolic engineering.

Authors:  Anne Richelle; Nathan E Lewis
Journal:  Curr Opin Syst Biol       Date:  2017-06-06

10.  An arginase-based system for selection of transfected CHO cells without the use of toxic chemicals.

Authors:  Berta Capella Roca; Nga Lao; Niall Barron; Padraig Doolan; Martin Clynes
Journal:  J Biol Chem       Date:  2019-10-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.